First Solar, Jive, Madison Square Garden: U.S. Equity Movers

Feb. 13 (Bloomberg) -- Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 4 p.m. in New York.

AmerisourceBergen Corp. (ABC US) sank 3.6 percent, the most
since Oct. 3, to $37.21. The drug distributor said Chief
Financial Officer Michael DiCandilo left the company.

Chelsea Therapeutics International Ltd. (CHTP US) dropped
the most in the Russell 2000 Index, sinking 38 percent to $3.11.
The biotechnology company said the Food and Drug Administration
has placed “increased emphasis on safety data” in its review
of the company’s Northera drug.

Complete Genomics Inc. (GNOM US) rose the most in the
Russell 2000 Index, rallying 42 percent to $4.66. The makers of
genomic analysis tools said it was picked by Mayo Clinic to
provide human genome sequencing.

Diebold Inc. (DBD US) rose 9.2 percent, the second-most in
the Russell 1000 Index, to $37.94. The maker of automated bank-teller machines forecast 2012 earnings per share of $2.30 to
$2.50 a share, compared with the average analyst estimate of
$2.31, and forecast sales growth of at least 3 percent, beating
the average estimate of 2 percent.

First Solar Inc. (FSLR US) had the biggest retreat in the
S&P 500, tumbling 5 percent to $41.72. The biggest maker of
thin-film solar panels may have no earnings growth over the next
two to three years, Bank of America Corp. wrote in a note today.
“We don’t think there’s a reason to chase the shares,” the
note said.

Jive Software Inc. (JIVE US) rose 8.6 percent to $18.54,
the highest since its initial public offering in December. The
social business software and services company gained after a
Barron’s story over the weekend highlighted its similarities to
Facebook Inc.

Madison Square Garden Co. (MSG US) gained 3.8 percent to
$32.32, rallying for the ninth straight day. The owner of the
New York Knicks basketball franchise has surged to a record as
Jeremy Lin jerseys became the best-seller in the National
Basketball Association, just over a week after the 23-year-old
player was a substitute on the team.

Regeneron Pharmaceuticals Inc. (REGN US) jumped 12 percent,
the most in the Russell 1000 Index, to $114.65. The drugmaker
reported a fourth-quarter adjusted loss per share that was
narrower than the average analyst estimate and increased its
2012 U.S. sales forecast for its Eylea treatment for a
blindness-causing eye disorder to at least $250 million from no
more than $160 million.

W.W. Grainger Inc. (GWW US) rose 4.2 percent to $208.46,
the highest price since at least 1980. The distributor of
building maintenance supplies reported January sales that grew
12 percent excluding acquisitions compared to a year earlier.